Johnson & Johnson suffers another setback as FDA tells Md. vaccine maker to suspend production Christopher Rowland © Saul Loeb/AFP/Getty Images The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson s coronavirus vaccine, in Baltimore, on April 9. Emergent BioSolutions has shut down new manufacturing of Johnson & Johnson’s coronavirus vaccine at its Baltimore plant at the request of the Food and Drug Administration after an inspection of the troubled facility last week, Emergent said Monday. The halt in production is another setback for Johnson & Johnson as it attempts to meet its promise to deliver nearly 100 million doses of vaccine to the U.S. government by the end of May.
Johnson & Johnson pauses vaccine production at Emergent plant at FDA request
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Pro-Life Leaders Assess Concerns About the Use of Abortion-Derived Cell Lines in Coronavirus Vaccines
breitbart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from breitbart.com Daily Mail and Mail on Sunday newspapers.
Pro-Life Leaders Assess Concerns About the Use of Abortion-Derived Cell Lines in Coronavirus Vaccines
breitbart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from breitbart.com Daily Mail and Mail on Sunday newspapers.